The challenge of recruiting patients into a placebo-controlled surgical trial

نویسندگان

  • Kristoffer B Hare
  • L Stefan Lohmander
  • Ewa M Roos
چکیده

BACKGROUND Randomized placebo-controlled trials represent the gold standard in evaluating healthcare interventions but are rarely performed within orthopedics. Ethical concerns or well-known challenges in recruiting patients for surgical trials in general have been expressed and adding a placebo component only adds to this complexity. The purpose of this study was to report the challenges of recruiting patients into an orthopedic placebo-controlled surgical trial, to determine the number of patients needed to be screened and allocated in order to include one participant into the trial, and to identify reasons associated with participation in a placebo-controlled randomized surgical trial. METHODS Data were extracted from an ongoing placebo-controlled randomized controlled trial (RCT) on meniscectomy versus placebo surgery. We calculated the number of patients needed to be screened in order to include the required number of participants into the RCT. Participating patients were asked about their rationale for joining the study and which type of information was most useful for deciding upon participation. RESULTS A total of 476 patients entered the screening group, of which 190 patients fulfilled the inclusion and exclusion criteria. 102 patients declined to participate in the study due to various reasons and 46 were later excluded (no meniscus lesion on the magnetic resonance imaging scan or withdrawn consent). A total of 40 patients were finally included in the RCT. To include one patient into the RCT, 11.9 individuals needed to be screened. A total of 69% of participating patients considered the oral information to be the most important and the most common reason for participating was the contribution to research (90%). CONCLUSIONS Patients are willing to participate in an orthopedic placebo-controlled surgical trial. Oral information given by the surgeon to the patient and the contribution to research are important aspects to enhance patient recruitment. TRIAL REGISTRATION ClinicalTrials.gov NCT01264991, registered 21 December 2010.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

بررسی اثر تجویز کلونیدین خوراکی قبل از عمل بر میزان خونریزی وکیفیت موضع جراحی حین عمل جراحی اندوسکوپی سینوس

                            Aim and Background:   Bleeding during functional endoscopic sinus surgery(FESS)remains a challenge for both surgeons and anesthesiologists despite several modalities available for improving the surgical field. This study was conducted to evaluate the effect of oral clonidine premedication on blood loss and the quality of...

متن کامل

A PROSPECTIV E, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL OF DEXAMETHASONE DURING THE FOLLICULAR PHASE IN CLOMIPHENE RESISTANT PATIENTS WITH POLYCYSTIC OVARY SYNDROME AND NORMAL DHEAS

In order to evaluate the effects of short course administration of dexamethasone (DEX) combined with clomiphene citrate (CC) in CC-resistant patients with polycystic ovary syndrome (PCaS) and normal DHEAS, a prospective, double blind, placebo controlled, randomized study was undertaken at referral university hospitals, Two-hundred and thirty women with PCOS and normal DHEAS who failed to ...

متن کامل

Predictors of Missed Research Appointments in a Randomized Placebo-Controlled Trial

Background:  The primary aim of this study was to determine predictors of missed research appointments in a prospective  andomized placebo injection-controlled trial with evaluations 1 to 3 and 5 to 8 months after enrollment.   Methods:  This study represents a secondary use of data from 104 patients that were enrolled in a prospective randomized  ontrolled trial of dexamethasone versus lidocai...

متن کامل

A double-blind, placebo-controlled evaluation of Vitex agnus castus premenstrual syndrom

The objective of this study was to assess the effect of Vitex agnus castus (VACS) extract in the alleviation of the symptoms of premenstrual syndrome. The study was designed as a double-blind, placebo controlled trial in two parallels groups (15 patients each). Treatment phase lasted 3 consequent menstrual cycles (2*30 drops/day=1.8 ml of VACS) or placebo. For assessment of the efficacy visual ...

متن کامل

A double-blind, placebo-controlled evaluation of Vitex agnus castus premenstrual syndrom

The objective of this study was to assess the effect of Vitex agnus castus (VACS) extract in the alleviation of the symptoms of premenstrual syndrome. The study was designed as a double-blind, placebo controlled trial in two parallels groups (15 patients each). Treatment phase lasted 3 consequent menstrual cycles (2*30 drops/day=1.8 ml of VACS) or placebo. For assessment of the efficacy visual ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 15  شماره 

صفحات  -

تاریخ انتشار 2014